ASX Share rice
Sun 09 May 2021 - 05:56:pm (Sydney)

IXC Share Price

INVEX THERAPEUTICS LTDIXCPharmaceuticals, Biotechnology & Life Sciences

IXC Company Information


Invex Therapeutics Ltd






38 Rowland Street Subiaco WA Australia 6008


61 8 6382 0137

CFO & Company Sec.:

Ms. Narelle Warren B.Com., L.L.B., B.Com, LLB

Exec. Director & Chief Scientific Officer:

Prof. Alexandra Jean Sinclair

Company Overview:

Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury that has completed Phase II clinical trial. The company was incorporated in 2019 and is based in Subiaco, Australia.

IXC Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Return On Assets (TTM):


Return On Equity (TTM):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


IXC CashFlow Statement

CashFlow Date:


Change To Liabilities:


Net Income:


Total Cash From Operating Activities:


Change To Account Receivables:


Sale Purchase Of Stock:


Capital Expenditures:


IXC Income Statement

Income Date:


Income Before Tax:


Net Income:


Operating Income:


Total Revenue:


IXC Balance Sheet

Balance Sheet Date:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Retained Earnings:




Total Current Liabilities:


Net Tangible Assets:


Total Current Assets:


Net Receivables:


Short-Term Investments:


Accounts Payable:


Short-Term Investments:


Non Current Liabilities Total:


IXC Share Price History

IXC News

13 Feb, 2021
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
01 Sep, 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although